title: Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13.
abstract: An integrated approach involving physical mapping, identification of transcribed sequences, and computational analysis of genomic sequence was used to generate a detailed transcription map of the 1. 0-Mb region containing the breast cancer susceptibility locus BRCA2 on chromosome 13q12-q13. This region is included in the genetic interval bounded by D13S1444 and D13S310. Retrieved sequences from exon amplification or hybrid selection procedures were grouped into physical intervals and subsequently grouped into transcription units by clone overlap. Overlap was established by direct hybridization, cDNA library screening, PCR cDNA linking (island hopping), and/or sequence alignment. Extensive genomic sequencing was performed in an effort to understand transcription unit organization. In total, approximately 500 kb of genomic sequence was completed. The transcription units were further characterized by hybridization to RNA from a series of human tissues. Evidence for seven genes, two putative pseudogenes, and nine additional putative transcription units was obtained. One of the transcription units was recently identified as BRCA2 but all others are novel genes of unknown function as only limited alignment to sequences in public databases was observed. One large gene with a transcript size of 10.7 kb showed significant similarity to a gene predicted by the Caenorhabditis elegans genome and the Saccharomyces cerevisiae genome sequencing efforts, while another contained a motif sequence similar to the human 2',3' cyclic nucleotide 3' phosphodiesterase gene. Several retrieved transcribed sequences were not aligned into transcription units because no corresponding cDNAs were obtained when screening libraries or because of a lack of definitive evidence for splicing signals or putative coding sequence based on computational analysis. However, the presence of additional genes in the BRCA2 interval is suggested as groups of putative exons and hybrid selected clones that were transcribed in consistent orientations could be localized to common physical intervals.
authors.affiliation: Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, USA.
authors.forename: F J
authors.initials: FJ
authors.lastname: Couch
authors.forename: J M
authors.initials: JM
authors.lastname: Rommens
authors.forename: S L
authors.initials: SL
authors.lastname: Neuhausen
authors.forename: C
authors.initials: C
authors.lastname: Bélanger
authors.forename: M
authors.initials: M
authors.lastname: Dumont
authors.forename: K
authors.initials: K
authors.lastname: Abel
authors.forename: R
authors.initials: R
authors.lastname: Bell
authors.forename: S
authors.initials: S
authors.lastname: Berry
authors.forename: R
authors.initials: R
authors.lastname: Bogden
authors.forename: L
authors.initials: L
authors.lastname: Cannon-Albright
authors.forename: L
authors.initials: L
authors.lastname: Farid
authors.forename: C
authors.initials: C
authors.lastname: Frye
authors.forename: T
authors.initials: T
authors.lastname: Hattier
authors.forename: T
authors.initials: T
authors.lastname: Janecki
authors.forename: P
authors.initials: P
authors.lastname: Jiang
authors.forename: R
authors.initials: R
authors.lastname: Kehrer
authors.forename: J F
authors.initials: JF
authors.lastname: Leblanc
authors.forename: J
authors.initials: J
authors.lastname: McArthur-Morrison
authors.forename: D
authors.initials: D
authors.lastname: Meney
authors.forename: Y
authors.initials: Y
authors.lastname: Miki
authors.forename: Y
authors.initials: Y
authors.lastname: Peng
authors.forename: C
authors.initials: C
authors.lastname: Samson
authors.forename: M
authors.initials: M
authors.lastname: Schroeder
authors.forename: S C
authors.initials: SC
authors.lastname: Snyder
authors.forename: J
authors.initials: J
authors.lastname: Simard
mesh_terms: D024682:BRCA2 Protein; D002874:Chromosome Mapping / Q000379:methods*; D002882:Chromosomes, Human, Pair 13 / Q000235:genetics*; D018076:DNA, Complementary / Q000235:genetics; D005091:Exons / Q000235:genetics; D005796:Genes / Q000235:genetics; D016147:Genes, Tumor Suppressor / Q000235:genetics*; D006801:Humans; D008969:Molecular Sequence Data; D009363:Neoplasm Proteins / Q000235:genetics*; D009928:Organ Specificity; D011544:Pseudogenes / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D017422:Sequence Analysis, DNA; D014157:Transcription Factors / Q000235:genetics*; D014158:Transcription, Genetic
chemical_list: D024682:BRCA2 Protein; D018076:DNA, Complementary; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D014157:Transcription Factors